Emerg Infect Dis. 2021 Feb;27(2):632-635. doi: 10.3201/eid2702.204168.
We developed an assay that detects minus-strand RNA as a surrogate for actively replicating severe acute respiratory syndrome coronavirus 2. We detected minus-strand RNA in 41 persons with coronavirus disease up to 30 days after symptom onset. This assay might inform clinical decision-making about patient infectiousness.
我们开发了一种检测负链 RNA 的检测方法,作为严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)正在复制的替代指标。我们在症状出现后长达 30 天的 41 名冠状病毒疾病患者中检测到了负链 RNA。该检测方法可能为临床判断患者的传染性提供依据。
Emerg Infect Dis. 2021-2
Int J Infect Dis. 2021-3
Emerg Infect Dis. 2021-2
Bol Med Hosp Infant Mex. 2021-5-3
Clin Microbiol Rev. 2024-6-13
Clin Lab Med. 2022-6
Commun Med (Lond). 2021-8-23
Clin Microbiol Infect. 2020-7-23
J Clin Virol. 2020-5-30
Clin Infect Dis. 2020-12-17
Clin Infect Dis. 2020-11-19
Emerg Infect Dis. 2020-5-8
Eur J Clin Microbiol Infect Dis. 2020-4-27
Nature. 2020-4-1